Department of Neurogenetics, Iranian Centre of Neurological Research, Tehran.
Int J Immunogenet. 2012 Oct;39(5):429-36. doi: 10.1111/j.1744-313X.2012.01116.x. Epub 2012 Apr 12.
Type 1 Diabetes mellitus (T1D) is an autoimmune and multifactorial disease. HLA-DRB1 and DQB1 loci have the strongest association with T1D. This study aimed at investigating (i) susceptibility or protection of alleles, genotypes and haplotypes of HLA-DRB1 and DQB1 loci; and (ii) highly polymorphic amino acid residues of HLA-DRβ1 and DQβ1 in 105 Iranian T1D patients and 100 controls. The results indicated that DRB104:01, 03:01, DQB103:02, 02:01 alleles, DRB103:01/04:01, 03:01/13:03, DQB102:01/03:02 genotypes, DRB104:01-DQB103:02, DRB103:01-DQB102:01, DRB107:01-DQB103:03 haplotypes had positive association with T1D. In contrast, HLA-DRB115:01, 13:01, DQB103:01, 06:01 alleles, DRB111:01/15:01, DQB103:01/06:01, 03:01/05:01 genotypes and DRB115:01-DQB106:01, DRB111:01-DQB103:01 haplotypes had negative association with T1D. Analysis of amino acid sequence of HLA-DRβ1 and DQβ1 revealed that DRβ1(Lys71+) and DQβ1(Asp57-) were significantly more frequent in patients than in controls and had a positive effect in the development of T1D. Haplotype analysis demonstrated that HLA-DRB1(Lys71+) allele provided major susceptibility for T1D, and DQβ1(Asp57-) had an additive effect. We designed an allele-specific primer to develop an easy, quick and cost-benefit method to detect the DRβ1(Lys71+) . This method can identify all 114 DRB1 alleles encoding DRβ1(Lys71+) by three PCR reactions. The PcPPV and PcNPV were also calculated to determine the impact of HLA genotype testing at amino acid positions. It showed that the DRβ1(Lys71+/+) genotype carrier had 1% absolute risk of developing T1D.
1 型糖尿病(T1D)是一种自身免疫性和多因素疾病。HLA-DRB1 和 DQB1 基因座与 T1D 关联最强。本研究旨在探讨(i)HLA-DRB1 和 DQB1 基因座等位基因、基因型和单倍型的易感性或保护性;(ii)105 例伊朗 T1D 患者和 100 例对照中 HLA-DRβ1 和 DQβ1 高度多态性的氨基酸残基。结果表明,DRB104:01、03:01、DQB103:02、02:01 等位基因、DRB103:01/04:01、03:01/13:03、DQB102:01/03:02 基因型、DRB104:01-DQB103:02、DRB103:01-DQB102:01、DRB107:01-DQB103:03 单倍型与 T1D 呈正相关。相反,HLA-DRB115:01、13:01、DQB103:01、06:01 等位基因、DRB111:01/15:01、DQB103:01/06:01、03:01/05:01 基因型和 DRB115:01-DQB106:01、DRB111:01-DQB103:01 单倍型与 T1D 呈负相关。HLA-DRβ1 和 DQβ1 氨基酸序列分析显示,DRβ1(Lys71+)和 DQβ1(Asp57-)在患者中明显比对照更频繁,对 T1D 的发生有积极影响。单倍型分析表明,HLA-DRB1(Lys71+)等位基因对 T1D 具有主要易感性,而 DQβ1(Asp57-)具有附加效应。我们设计了一种等位基因特异性引物,开发了一种简单、快速且具有成本效益的方法来检测 DRβ1(Lys71+)。该方法可以通过三个 PCR 反应鉴定所有 114 个编码 DRβ1(Lys71+)的 DRB1 等位基因。还计算了 PcPPV 和 PcNPV 以确定在氨基酸位置进行 HLA 基因型检测的影响。结果表明,DRβ1(Lys71+/+)基因型携带者发生 T1D 的绝对风险为 1%。